Related Experiment Videos
EBM/11 reactivity in malignant histiocytosis.
P M Kelly1, M McGovern, K C Gatter
1University of Oxford, Nuffield Department of Pathology, John Radcliffe Hospital.
Journal of Clinical Pathology
|December 1, 1988
Summary
Malignant histiocytosis was diagnosed in a patient with a testicular mass. The EBM/11 antibody, targeting the mononuclear phagocyte system, aided in identifying the tumor cells, proving useful for classifying histiocytic malignancies.
Area of Science:
- Oncology
- Immunohistochemistry
- Pathology
Background:
- Malignant histiocytosis is a rare neoplastic proliferation of histiocytes.
- Testicular masses can present with diverse histopathological features, sometimes leading to diagnostic challenges.
- Accurate tumor classification is crucial for appropriate treatment and prognosis.
Purpose of the Study:
- To report a case of malignant histiocytosis presenting as a testicular mass.
- To evaluate the utility of the EBM/11 monoclonal antibody in diagnosing histiocytic tumors.
- To demonstrate the role of immunohistochemistry in differentiating poorly differentiated malignancies.
Main Methods:
- Histopathological examination of a testicular biopsy.
- Immunohistochemical staining using the EBM/11 monoclonal antibody.
- Clinical and laboratory investigations for diagnosis confirmation.
Main Results:
- Biopsy revealed morphological features consistent with malignant histiocytosis.
- Tumor cells exhibited strong positive labeling with the EBM/11 antibody.
- The antibody demonstrated high specificity for cells of the human mononuclear phagocyte system.
Conclusions:
- The EBM/11 antibody is a valuable tool for the positive identification of malignant histiocytosis.
- Immunohistochemistry, particularly with EBM/11, can aid in classifying tumors where morphology is inconclusive.
- This antibody assists in distinguishing histiocytic malignancies from other tumor types.